UTMD icon

Utah Medical Products

61.02 USD
-1.06
1.71%
At close Dec 20, 4:00 PM EST
After hours
61.02
+0.00
0.00%
1 day
-1.71%
5 days
-2.76%
1 month
-4.92%
3 months
-7.98%
6 months
-8.97%
Year to date
-26.90%
1 year
-27.86%
5 years
-43.86%
10 years
7.05%
 

About: Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.

Employees: 190

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

90% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 10

72% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 25

9% more funds holding

Funds holding: 101 [Q2] → 110 (+9) [Q3]

0.3% less ownership

Funds ownership: 69.51% [Q2] → 69.21% (-0.3%) [Q3]

2% less capital invested

Capital invested by funds: $164M [Q2] → $161M (-$3.31M) [Q3]

Research analyst outlook

We haven’t received any recent analyst ratings for UTMD.

Financial journalist opinion

Neutral
Accesswire
1 month ago
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, who was employed in direct sales positions for UTMD from 2004 to 2016, graduated with a B.S.
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
Neutral
Zacks Investment Research
1 month ago
Utah Medical Q3 Earnings Decline Y/Y on Lower OEM Sales
UTMD reports a 5.2% EPS decline in Q3 2024, with revenues declining 20% due to reduced OEM and Filshie sales. Cost controls helped stabilize profit margins.
Utah Medical Q3 Earnings Decline Y/Y on Lower OEM Sales
Neutral
Accesswire
1 month ago
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were weaker on the top line, but better on the bottom line, compared to its beginning of year projections. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros.
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
Neutral
Accesswire
4 months ago
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on October 4, 2024 to stockholders of record at the close of business on September 20, 2024. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.
Utah Medical Products, Inc. Announces Quarterly Dividend
Negative
Zacks Investment Research
4 months ago
Utah Medical (UTMD) Q2 EPS Falls Y/Y on Lower Key Customer Sales
Utah Medical (UTMD) reports a 19.2% revenue decline in 2Q24, with EPS down 15.3% due to lower sales to major customers. Despite this, profit margins remained stable.
Utah Medical (UTMD) Q2 EPS Falls Y/Y on Lower Key Customer Sales
Neutral
Accesswire
4 months ago
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / As previously projected, Utah Medical Products, Inc. (Nasdaq:UTMD) realized second calendar quarter (2Q) and first half (1H) 2024 financial results which reflect a substantial decline in revenues. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros.
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
Positive
Zacks Investment Research
6 months ago
Zacks Initiates Coverage of UTMD With Neutral Recommendation
Explore why Zacks rates UTMD with a "Neutral" recommendation, being the first on Wall Street to initiate coverage on the stock. Learn about UTMD's financial stability, diverse product portfolio, and market opportunities, balanced against key challenges in the competitive medical device industry.
Neutral
Accesswire
7 months ago
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / May 7, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on July 5, 2024 to stockholders of record at the close of business on June 14, 2024. This is a 1.7% increase over the dividend declared in the same quarter of the prior year.
Utah Medical Products, Inc. Announces Quarterly Dividend
Neutral
Accesswire
7 months ago
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously announced projections for calendar year 2024. Summary of results.
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
Positive
The Motley Fool
8 months ago
2 Beaten-Down Stocks That Could Be Ready to Soar
These beaten-down stocks have lots of long-term potential.
2 Beaten-Down Stocks That Could Be Ready to Soar
Charts implemented using Lightweight Charts™